Heterogeneity in response to Elexacaftor/Tezacaftor/Ivacaftor in people with cystic fibrosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Heterogeneity in response to Elexacaftor/Tezacaftor/Ivacaftor in people with cystic fibrosis

Published:2024-05 Issue: Volume: Page:
ISSN:1569-1993
Container-title:Journal of Cystic Fibrosis
language:en
Short-container-title:Journal of Cystic Fibrosis

Author:

Alicandro Gianfranco,Gramegna Andrea^ORCID,Bellino Federica^ORCID,Sciarrabba Sathya Calogero,Lanfranchi Chiara,Contarini Martina^ORCID,Retucci Mariangela,Daccò Valeria,Blasi Francesco^ORCID

Publisher

Elsevier BV

Reference24 articles.

1. Cystic fibrosis;Elborn;Lancet,2016

2. From Ivacaftor to triple combination: a systematic review of efficacy and safety of CFTR modulators in people with cystic fibrosis;Gramegna;Int J Mol Sci,2020

3. Standards of care for CFTR variant-specific therapy (including modulators) for people with cystic fibrosis;Southern;J Cyst Fibros,2023

4. VX17-445-103 Trial Group. Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial;Heijerman;Lancet,2019

5. VX17-445-102 Study Group. Elexacaftor-Tezacaftor-Ivacaftor for cystic fibrosis with a single Phe508del Allele;Middleton;N Engl J Med,2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene expression responses of CF airway epithelial cells exposed to elexacaftor/tezacaftor/ivacaftor (ETI) suggest benefits beyond improved CFTR channel function;2024-08-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP